A Nigerian-born chemist based in the United States, Kaothar Olurode Adeleke, has announced plans to open an independent contract analytical testing laboratory. The lab will focus on preventing drug shortages and improving quality control in pharmaceuticals.
The initiative is part of Adeleke’s broader efforts to enhance drug safety standards globally. The laboratory will conduct analytical testing for pharmaceutical companies, ensuring compliance with regulatory requirements. Adeleke, who has worked in the US pharmaceutical industry for several years, aims to provide an alternative to existing testing services.
Adeleke’s background in chemistry and pharmaceutical research has positioned her to address gaps in the current testing infrastructure. The new lab will operate independently, offering services to companies seeking reliable and transparent testing results. The project is expected to create local employment opportunities and support the US healthcare sector.
The move comes amid growing concerns about drug shortages and inconsistent quality control in the pharmaceutical supply chain. Adeleke’s lab will focus on critical areas such as active pharmaceutical ingredient analysis and formulation testing. The project is currently in the planning phase, with expected operational start by early next year.
